Supplementary Data from Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent Resistance

Authors :: Pasi A. Jänne
Stephen Wang
Sujuan Guo
Jiannan Guo
Paul T. Kirschmeier
Jens Köhler
Zihan Wei
Fangxin Hong
Pratik R. Chopade
Prafulla C. Gokhale
Christie J. Lau
Kshiti H. Dholakia
Nam Doo Kim
Taebo Sim
Luke J. Taus
Yanan Kuang
Cloud P. Paweletz
Magda Bahcall
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figures S1-3; Supplementary Tables S1-3

Full Text Access

Tools